Wernicke's encephalopathy : An excitotoxicity hypothesis

Thiamine deficiency is a recognized cause of Wernicke's encephalopathy (WE), a condition in which small necrotic lesions are found in close proximity to the third and fourth ventricles and the Sylvian aqueduct. Although the neuropathology of WE is well-established, the pathogenic mechanisms tha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Metabolic brain disease 1997-09, Vol.12 (3), p.183-192
1. Verfasser: MCENTEE, W. J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 192
container_issue 3
container_start_page 183
container_title Metabolic brain disease
container_volume 12
creator MCENTEE, W. J
description Thiamine deficiency is a recognized cause of Wernicke's encephalopathy (WE), a condition in which small necrotic lesions are found in close proximity to the third and fourth ventricles and the Sylvian aqueduct. Although the neuropathology of WE is well-established, the pathogenic mechanisms that determine the formation and distribution of brain lesions identified with this illness are not understood. It is proposed here that glutamate neurotoxicity causes the brain lesions in WE. Glutamic acid decarboxylase (GAD), an enzyme mainly confined to the central nervous system, protects most regions of the brain from glutamate that accumulates when the activity of alpha-ketoglutarate dehydrogenase, a thiamine-dependent enzyme complex, is reduced. During severe thiamine deficiency, glutamate accumulates in GAD-free peripheral tissues and reaches a concentration in blood at which it passes through circumventricular organs into the cerebral ventricles or contiguous brain and finally diffuses into the extracellular space of proximate diencephalic and brain stem tissues. Extracellular glutamate eventually reaches neurotoxic levels in those tissues and causes the characteristic lesions of WE.
doi_str_mv 10.1007/BF02674611
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16432938</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>532723061</sourcerecordid><originalsourceid>FETCH-LOGICAL-c301t-5f2da04449f412eb0306990fa54ce31ccab9b99affd2420d35d3dfafca1f73d13</originalsourceid><addsrcrecordid>eNpd0M1LwzAYBvAgypzTi3ehiCgI1TcfTRpvczgVBl4UjyVNE9rZNbVpYf3vraxM8PQenh8PLw9C5xjuMIC4f1wC4YJxjA_QFEeChoLy6BBNIY6jUDAJx-jE-zUA0AjLCZpIyjjjYoriT9NUhf4yNz4wlTZ1rkpXqzbvg4dgXgVmq4vWtW5bDLcP8r52bW584U_RkVWlN2fjnaGP5dP74iVcvT2_LuarUFPAbRhZkilgjEnLMDEpUOBSglUR04ZirVUqUymVtRlhBDIaZTSzymqFraAZpjN0veutG_fdGd8mm8JrU5aqMq7zCeaMEknjAV7-g2vXNdXwW0IIxhIiygd0u0O6cd43xiZ1U2xU0ycYkt8tk78tB3wxNnbpxmR7Oo435FdjrrxWpW1UpQu_ZyRmPBZAfwDzHHo6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221190536</pqid></control><display><type>article</type><title>Wernicke's encephalopathy : An excitotoxicity hypothesis</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>MCENTEE, W. J</creator><creatorcontrib>MCENTEE, W. J</creatorcontrib><description>Thiamine deficiency is a recognized cause of Wernicke's encephalopathy (WE), a condition in which small necrotic lesions are found in close proximity to the third and fourth ventricles and the Sylvian aqueduct. Although the neuropathology of WE is well-established, the pathogenic mechanisms that determine the formation and distribution of brain lesions identified with this illness are not understood. It is proposed here that glutamate neurotoxicity causes the brain lesions in WE. Glutamic acid decarboxylase (GAD), an enzyme mainly confined to the central nervous system, protects most regions of the brain from glutamate that accumulates when the activity of alpha-ketoglutarate dehydrogenase, a thiamine-dependent enzyme complex, is reduced. During severe thiamine deficiency, glutamate accumulates in GAD-free peripheral tissues and reaches a concentration in blood at which it passes through circumventricular organs into the cerebral ventricles or contiguous brain and finally diffuses into the extracellular space of proximate diencephalic and brain stem tissues. Extracellular glutamate eventually reaches neurotoxic levels in those tissues and causes the characteristic lesions of WE.</description><identifier>ISSN: 0885-7490</identifier><identifier>EISSN: 1573-7365</identifier><identifier>DOI: 10.1007/BF02674611</identifier><identifier>PMID: 9346467</identifier><identifier>CODEN: MBDIEE</identifier><language>eng</language><publisher>New York, NY: Springer</publisher><subject>Animals ; Biological and medical sciences ; Brain - metabolism ; Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes ; gamma-Aminobutyric Acid - metabolism ; Glutamic Acid - physiology ; Humans ; Medical sciences ; Models, Neurological ; Nervous system (semeiology, syndromes) ; Neurology ; Neurotoxins - metabolism ; Thiamine Deficiency - complications ; Wernicke Encephalopathy - etiology</subject><ispartof>Metabolic brain disease, 1997-09, Vol.12 (3), p.183-192</ispartof><rights>1997 INIST-CNRS</rights><rights>Copyright Kluwer Academic Publishers Sep 1997</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c301t-5f2da04449f412eb0306990fa54ce31ccab9b99affd2420d35d3dfafca1f73d13</citedby><cites>FETCH-LOGICAL-c301t-5f2da04449f412eb0306990fa54ce31ccab9b99affd2420d35d3dfafca1f73d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27926,27927</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2846870$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9346467$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MCENTEE, W. J</creatorcontrib><title>Wernicke's encephalopathy : An excitotoxicity hypothesis</title><title>Metabolic brain disease</title><addtitle>Metab Brain Dis</addtitle><description>Thiamine deficiency is a recognized cause of Wernicke's encephalopathy (WE), a condition in which small necrotic lesions are found in close proximity to the third and fourth ventricles and the Sylvian aqueduct. Although the neuropathology of WE is well-established, the pathogenic mechanisms that determine the formation and distribution of brain lesions identified with this illness are not understood. It is proposed here that glutamate neurotoxicity causes the brain lesions in WE. Glutamic acid decarboxylase (GAD), an enzyme mainly confined to the central nervous system, protects most regions of the brain from glutamate that accumulates when the activity of alpha-ketoglutarate dehydrogenase, a thiamine-dependent enzyme complex, is reduced. During severe thiamine deficiency, glutamate accumulates in GAD-free peripheral tissues and reaches a concentration in blood at which it passes through circumventricular organs into the cerebral ventricles or contiguous brain and finally diffuses into the extracellular space of proximate diencephalic and brain stem tissues. Extracellular glutamate eventually reaches neurotoxic levels in those tissues and causes the characteristic lesions of WE.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Brain - metabolism</subject><subject>Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes</subject><subject>gamma-Aminobutyric Acid - metabolism</subject><subject>Glutamic Acid - physiology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Models, Neurological</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Neurotoxins - metabolism</subject><subject>Thiamine Deficiency - complications</subject><subject>Wernicke Encephalopathy - etiology</subject><issn>0885-7490</issn><issn>1573-7365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpd0M1LwzAYBvAgypzTi3ehiCgI1TcfTRpvczgVBl4UjyVNE9rZNbVpYf3vraxM8PQenh8PLw9C5xjuMIC4f1wC4YJxjA_QFEeChoLy6BBNIY6jUDAJx-jE-zUA0AjLCZpIyjjjYoriT9NUhf4yNz4wlTZ1rkpXqzbvg4dgXgVmq4vWtW5bDLcP8r52bW584U_RkVWlN2fjnaGP5dP74iVcvT2_LuarUFPAbRhZkilgjEnLMDEpUOBSglUR04ZirVUqUymVtRlhBDIaZTSzymqFraAZpjN0veutG_fdGd8mm8JrU5aqMq7zCeaMEknjAV7-g2vXNdXwW0IIxhIiygd0u0O6cd43xiZ1U2xU0ycYkt8tk78tB3wxNnbpxmR7Oo435FdjrrxWpW1UpQu_ZyRmPBZAfwDzHHo6</recordid><startdate>19970901</startdate><enddate>19970901</enddate><creator>MCENTEE, W. J</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>19970901</creationdate><title>Wernicke's encephalopathy : An excitotoxicity hypothesis</title><author>MCENTEE, W. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c301t-5f2da04449f412eb0306990fa54ce31ccab9b99affd2420d35d3dfafca1f73d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Brain - metabolism</topic><topic>Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes</topic><topic>gamma-Aminobutyric Acid - metabolism</topic><topic>Glutamic Acid - physiology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Models, Neurological</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Neurotoxins - metabolism</topic><topic>Thiamine Deficiency - complications</topic><topic>Wernicke Encephalopathy - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MCENTEE, W. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Psychology Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Metabolic brain disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MCENTEE, W. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Wernicke's encephalopathy : An excitotoxicity hypothesis</atitle><jtitle>Metabolic brain disease</jtitle><addtitle>Metab Brain Dis</addtitle><date>1997-09-01</date><risdate>1997</risdate><volume>12</volume><issue>3</issue><spage>183</spage><epage>192</epage><pages>183-192</pages><issn>0885-7490</issn><eissn>1573-7365</eissn><coden>MBDIEE</coden><abstract>Thiamine deficiency is a recognized cause of Wernicke's encephalopathy (WE), a condition in which small necrotic lesions are found in close proximity to the third and fourth ventricles and the Sylvian aqueduct. Although the neuropathology of WE is well-established, the pathogenic mechanisms that determine the formation and distribution of brain lesions identified with this illness are not understood. It is proposed here that glutamate neurotoxicity causes the brain lesions in WE. Glutamic acid decarboxylase (GAD), an enzyme mainly confined to the central nervous system, protects most regions of the brain from glutamate that accumulates when the activity of alpha-ketoglutarate dehydrogenase, a thiamine-dependent enzyme complex, is reduced. During severe thiamine deficiency, glutamate accumulates in GAD-free peripheral tissues and reaches a concentration in blood at which it passes through circumventricular organs into the cerebral ventricles or contiguous brain and finally diffuses into the extracellular space of proximate diencephalic and brain stem tissues. Extracellular glutamate eventually reaches neurotoxic levels in those tissues and causes the characteristic lesions of WE.</abstract><cop>New York, NY</cop><pub>Springer</pub><pmid>9346467</pmid><doi>10.1007/BF02674611</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0885-7490
ispartof Metabolic brain disease, 1997-09, Vol.12 (3), p.183-192
issn 0885-7490
1573-7365
language eng
recordid cdi_proquest_miscellaneous_16432938
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Animals
Biological and medical sciences
Brain - metabolism
Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes
gamma-Aminobutyric Acid - metabolism
Glutamic Acid - physiology
Humans
Medical sciences
Models, Neurological
Nervous system (semeiology, syndromes)
Neurology
Neurotoxins - metabolism
Thiamine Deficiency - complications
Wernicke Encephalopathy - etiology
title Wernicke's encephalopathy : An excitotoxicity hypothesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T19%3A12%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Wernicke's%20encephalopathy%20:%20An%20excitotoxicity%20hypothesis&rft.jtitle=Metabolic%20brain%20disease&rft.au=MCENTEE,%20W.%20J&rft.date=1997-09-01&rft.volume=12&rft.issue=3&rft.spage=183&rft.epage=192&rft.pages=183-192&rft.issn=0885-7490&rft.eissn=1573-7365&rft.coden=MBDIEE&rft_id=info:doi/10.1007/BF02674611&rft_dat=%3Cproquest_cross%3E532723061%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=221190536&rft_id=info:pmid/9346467&rfr_iscdi=true